Sign up
Log in
12 Health Care Stocks Moving In Monday's Pre-Market Session
Share
Listen to the news

Gainers

  • Capstone Holding (NASDAQ:CAPS) shares increased by 107.6% to $5.19 during Monday's pre-market session. The company's market cap stands at $7.3 million.
  • Aclarion (NASDAQ:ACON) stock rose 39.89% to $1.08. The company's market cap stands at $1.0 million.
  • Quantum-Si (NASDAQ:QSI) shares rose 19.85% to $1.63. The company's market cap stands at $258.0 million.
  • Annexon (NASDAQ:ANNX) shares moved upwards by 19.23% to $3.1. The company's market cap stands at $340.1 million.
  • Senti Biosciences (NASDAQ:SNTI) shares increased by 17.47% to $4.1. The market value of their outstanding shares is at $19.8 million.
  • CEL-SCI (AMEX:CVM) stock moved upwards by 14.63% to $0.35. The market value of their outstanding shares is at $26.9 million.

Losers

  • Revelation Biosciences (NASDAQ:REVB) shares decreased by 25.0% to $2.55 during Monday's pre-market session. The company's market cap stands at $2.3 million.
  • Context Therapeutics (NASDAQ:CNTX) stock decreased by 22.29% to $0.55. The market value of their outstanding shares is at $41.1 million.
  • Incyte (NASDAQ:INCY) shares fell 14.9% to $57.75. The market value of their outstanding shares is at $11.1 billion.
  • Palisade Bio (NASDAQ:PALI) stock declined by 12.55% to $0.87. The company's market cap stands at $2.5 million.
  • Maze Therapeutics (NASDAQ:MAZE) shares declined by 11.65% to $9.71. The company's market cap stands at $425.0 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares declined by 9.46% to $0.34. The market value of their outstanding shares is at $1.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.